Navigation Links
Newer Generation Sleeping Pills Lack Superior Performance

The increasing number of people resorting to sleeping pills for treatment of insomnia has no doubt prompted for invention of more effective medications. However, they may not have the best clinical// benefits according to a new review study conducted recently.

The importance of sleep can be inferred form the statement ‘Early to bed, early to rise makes a man healthy, wealthy and wise’. For those of them who are deprived this wonderful gift, there are the new generation sleeping pills that substitute the previously used benzodiazepines. These new class of medications were introduced in 1992 for commercial use and are still regarded to be better compared to benzodiazepines due to the reduced risk of habit formation over a period of time.

A detailed review regarding the safety and effectiveness of the sleeping pills concluded that the drugs were better than placebo pills for treatment of insomnia symptoms such as trouble falling asleep and staying asleep. No drug was found to have a superior outcome even if used consistently. Researchers from the Oregon Health and Science University were involved in the study.

The review team analyzed nearly data from 141 different studies of the new- generation sleeping pills and found that different effects were pronounced in different users. For example, one drug was found to be effective in putting people to sleep while the other was found to enhance the sleep quality.

‘Although there are some differences among the drugs on the different outcomes, it does not follow that one drug would necessarily be more or less effective for patients with one type of insomnia over another. We found no studies comparing the different drugs in patients with different insomnia complaints, so we do not know for sure that one drug would work better in one patient over another’, said Carson, a member of the review team.

Short-term side effects such as headaches and daytime sleepiness were fou nd to occur at similar rates among the drugs studied. Furthermore, the incidences of hip fractures were found to be higher in older women who took sleep medication compared to those who didn’t.

Comparative studies to establish the therapeutic benefits of the newer generation drugs over benzodiazepines are also needed in view of the fact that more than 70 million Americans have sleeping trouble, according to estimates by the National Institutes of Health. More studies to assess the long-term adverse effects such as bone fractures; abuse and withdrawal symptoms are clearly indicated at the momet.
'"/>




Related medicine news :

1. The Efficacy Of Newer Stents Questioned
2. Autoimmune Diseases – Newer Preventive Measure
3. Need for Newer AIDS Drugs In China
4. Newer Blood Pressure Drugs Decrease Risk Of Diabetes
5. Newer Antidepressants May Trigger Violent Behavior
6. Newer Class of Antidepressants Similar in Effectiveness, Side Effects Differ
7. Study Sheds Light on Value of Newer Antipsychotic Drugs for Schizophrenia
8. Cellulose Nanocrystal Research Paves the Way for Newer Vaccines, Computer Inks
9. Hearing Problems Of Middle Age Are Affecting The Younger Generation
10. Tigecycline – New Generation Tetracycline With Broad Spectrum Antibacterial Activit
11. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... SEOUL, South Korea , Oct. 4, 2017 /PRNewswire/ ... launched its next-generation CPR training aide "cprCUBE" on Kickstarter. ... of chest compression during cardiac arrests with better efficiency ... patient-mannequins. It also offers real-time feedback on efficacy of ... The crowdfunding campaign has a goal to raise ...
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology: